Mequitazine
![]() | This article may require cleanup to meet Wikipedia's quality standards. The specific problem is: Convert long prose list(s) to bulleted list(s). (March 2021) |
![]() | |
Clinical data | |
---|---|
Trade names | Primalan |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.005 |
Chemical and physical data | |
Formula | C20H22N2S |
Molar mass | 322.47 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Mequitazine (trade name Primalan) is an H1 antagonist and anticholinergic of the phenothiazine chemical class. It is used to treat allergies and rhinitis.
It was patented in 1969 and came into medical use in 1976.[2]
Contraindications
Severe liver disease; premature infants or full-term neonates.
Special precautions
Pregnancy, lactation; severe cardiovascular disorders; asthma; angle-closure glaucoma, urinary retention, prostatic hyperplasia, pyloroduodenal obstruction; renal and hepatic impairment; elderly, children; epilepsy. May impair ability to drive or operate machinery.
Adverse reactions
CNS depression including slight drowsiness to deep sleep, lassitude, dizziness, incoordination. Headache, psychomotor impairment and antimuscarinic effects. Rarely, rashes and hypersensitivity reactions, blood disorders, convulsions, sweating, myalgia, paraesthesias, extrapyramidal effects, tremor, confusion, sleep and GI disturbances, tinnitus, hypotension, hair loss. Photosensitivity, jaundice.
Drug interactions
Enhances effects of CNS depressants e.g. alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytics and antipsychotics. Can mask signs of ototoxicity caused by aminoglycosides. QT prolongation (which can lead to torsades de pointes arrhythmia) reported with spiramycin.
References
- ^ https://www.ema.europa.eu/documents/psusa/mequitazine-list-nationally-authorised-medicinal-products-psusa/00001986/202001_en.pdf[bare URL PDF]
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 548. ISBN 9783527607495.
Further reading
- Ramírez Chanona N, del Rio Navarro BE, Pérez Martín J (November–December 2005). "[Efficacy of mequitazine (Primalan) on the relief of symptoms of allergic rhinoconjunctivitis in children. Documented clinical experience]". Revista Alergia Mexico (in Spanish). 52 (6): 221–5. PMID 16568706.
- Theunissen EL, Vermeeren A, van Oers AC, van Maris I, Ramaekers JG (February 2004). "A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo". Clinical and Experimental Allergy. 34 (2): 250–8. doi:10.1111/j.1365-2222.2004.01874.x. PMID 14987305. S2CID 23019669.
- Nakamura K, Yokoi T, Kodama T, Inoue K, Nagashima K, Shimada N, et al. (February 1998). "Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes" (PDF). The Journal of Pharmacology and Experimental Therapeutics. 284 (2): 437–42. PMID 9454781.
- Persi L, Dupin O, Arnaud B, Trinquand C, Michel FB, Bousquet J (April 1997). "Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis". Allergy. 52 (4): 451–4. doi:10.1111/j.1398-9995.1997.tb01028.x. PMID 9188930. S2CID 34785561.
External links
- "Mequitazine". Drug Information Portal. U.S. National Library of Medicine.
- All articles with bare URLs for citations
- Articles with bare URLs for citations from March 2022
- Articles with PDF format bare URLs for citations
- Articles with short description
- Short description matches Wikidata
- Articles needing cleanup from March 2021
- All pages needing cleanup
- Cleanup tagged articles with a reason field from March 2021
- Wikipedia pages needing cleanup from March 2021
- Drugs with non-standard legal status
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- CS1 Spanish-language sources (es)
- H1 receptor antagonists
- Muscarinic antagonists
- Phenothiazines
- Quinuclidines